Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction: A Randomized, Controlled Trial

NCT04680442 is registered in ClinicalTrials.gov with Population Health Research Institute as lead sponsor.

NCT NCT04680442
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04680442 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction: A Randomized, Controlled Trial
Lead sponsor
Population Health Research Institute
Phase
Phase 2
Overall status
Recruiting
Start date
July 1, 2021
Completion date
June 30, 2026
Enrollment
130 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, heart failure